The UK life sciences sector is in the middle of a structural shift that comes along once in a generation. A government committing up to £1 billion in manufacturing and R&D investment. A biotech VC market recovering sharply, with £552 million raised in Q1 2026 alone, up 17% quarter-on-quarter. Clinical trial reform cutting setup times from 250 days to 122. And a wave of international M&A – from Eli Lilly to Amgen – validating UK-originated science assets at the highest levels.

Behind all of it is real estate. 3.7 million square feet of lab and innovation space under construction across London, Oxford and Cambridge. A £1 billion expansion at the London Cancer Hub. A £3 billion land deal at the Cambridge Biomedical Campus. And a pipeline of new clusters, from Whitechapel to White City, from Manchester to the Oxford-Cambridge Arc, transforming where UK science happens and who profits from it.

For CRE professionals, this is the moment. The deals are moving. The capital is flowing. The occupiers — biotechs, pharma, academia, NHS — are actively looking for space. The question is not whether this sector will grow. The question is who will be in the room when it does.

Five Questions This Summit Will Answer

– Where are the real investment opportunities in UK life sciences real estate — and which markets are already overheated?
– How is the government’s £1 billion life sciences investment programme reshaping development economics — and how can developers and investors access it?
– What do life sciences occupiers actually need from their real estate in 2026 — and are developers building the right product?
– As M&A activity accelerates and UK biotech assets attract global acquirers, how does that reshape the occupier base — and what does it mean for lease risk?
– How are the UK’s emerging clusters — Manchester, Birmingham, the Oxford-Cambridge Arc — closing the gap on London, and what does a winning regional life sciences strategy actually look like?

How You’ll Do More Business

The UK life sciences real estate market is not a niche. It is the fastest-growing, most policy-backed, most internationally validated commercial real estate opportunity in Britain right now — and the window to establish position is compressing fast. The developers, investors, and advisors who build relationships in this sector today will be the ones executing the deals of the next decade. This summit exists to accelerate that process.

Questions about your ticket purchase or interested in sponsoring? Reach out to customerservice@bisnow.com for customer support.

For questions, recommendations, comments, or press inquiries please email our VP of Production, Elizabeth Baker, at liz.baker@bisnow.com

To request disability-related accommodations, please contact lucrezia.manzo@bisnow.com no later than seven business days before the event.